| Předmět: |
|
| Zdroj: |
Clinical Trials Week; 9/11/2023, p1731-1731, 1p |
| Abstrakt: |
In head and neck squamous cell carcinoma (HNSCC), nimorazole, an oxygen mimic, combined with radiotherapy (RT) enabled to improve loco-regional control (LRC) in some patients with hypoxic tumors but it is unknown whether this holds also for radiochemotherapy (RCTx)." Keywords: Antibiotics; Biomarkers; Biotechnology; Clinical Research; Clinical Trials and Studies; Diagnostics and Screening; Drugs and Therapies; Emerging Technologies; Gene Expression Analysis; Health and Medicine; Machine Learning; Nimorazole; Nimorazole Therapy; Nitroimidazoles; Pharmaceuticals; Prognostic Markers; Radiotherapy; Xenografts; Xenotransplantion EN Antibiotics Biomarkers Biotechnology Clinical Research Clinical Trials and Studies Diagnostics and Screening Drugs and Therapies Emerging Technologies Gene Expression Analysis Health and Medicine Machine Learning Nimorazole Nimorazole Therapy Nitroimidazoles Pharmaceuticals Prognostic Markers Radiotherapy Xenografts Xenotransplantion 1731 1731 1 09/11/23 20230911 NES 230911 2023 SEP 11 (NewsRx) -- By a News Reporter-Staff News Editor at Clinical Trials Week -- A new study on xenografts is now available. [Extracted from the article] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
